Advanced Ccrcc clinical trials

Explore recruiting advanced ccrcc clinical trials.

Recruiting advanced ccrcc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Ccrcc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma

Sweden, Poland, France, Germany, Italy, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Ccrcc trials by city

Advanced Ccrcc in Toronto Advanced Ccrcc in Vancouver Advanced Ccrcc in Montreal Advanced Ccrcc in Calgary Advanced Ccrcc in Edmonton Advanced Ccrcc in Ottawa Advanced Ccrcc in Winnipeg Advanced Ccrcc in Quebec City Advanced Ccrcc in Hamilton Advanced Ccrcc in Kitchener Advanced Ccrcc in London Advanced Ccrcc in Halifax Advanced Ccrcc in New York Advanced Ccrcc in Los Angeles Advanced Ccrcc in Chicago Advanced Ccrcc in Houston

Advanced Ccrcc clinical trials

Recruiting advanced ccrcc studies right now

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Also recruiting in Europe

A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma

Advanced Ccrcc trials by city

Other conditions